PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CLOV vs. AUR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CLOVAUR
YTD Return223.50%23.11%
1Y Return201.96%157.42%
3Y Return (Ann)-25.93%-18.11%
Sharpe Ratio2.421.69
Sortino Ratio3.212.39
Omega Ratio1.381.29
Calmar Ratio2.111.71
Martin Ratio12.534.85
Ulcer Index16.36%30.95%
Daily Std Dev84.61%88.66%
Max Drawdown-97.19%-93.34%
Current Drawdown-86.09%-68.56%

Fundamentals


CLOVAUR
Market Cap$1.63B$9.28B
EPS-$0.19-$0.47
Total Revenue (TTM)$1.54B$0.00
Gross Profit (TTM)$522.63M-$48.00M
EBITDA (TTM)-$68.65M-$741.00M

Correlation

-0.50.00.51.00.4

The correlation between CLOV and AUR is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CLOV vs. AUR - Performance Comparison

In the year-to-date period, CLOV achieves a 223.50% return, which is significantly higher than AUR's 23.11% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%JuneJulyAugustSeptemberOctoberNovember
229.71%
94.22%
CLOV
AUR

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. AUR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Aurora Innovation, Inc. (AUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOV
Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at 2.42, compared to the broader market-4.00-2.000.002.004.002.42
Sortino ratio
The chart of Sortino ratio for CLOV, currently valued at 3.21, compared to the broader market-4.00-2.000.002.004.006.003.21
Omega ratio
The chart of Omega ratio for CLOV, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for CLOV, currently valued at 2.11, compared to the broader market0.002.004.006.002.11
Martin ratio
The chart of Martin ratio for CLOV, currently valued at 12.53, compared to the broader market0.0010.0020.0030.0012.53
AUR
Sharpe ratio
The chart of Sharpe ratio for AUR, currently valued at 1.69, compared to the broader market-4.00-2.000.002.004.001.69
Sortino ratio
The chart of Sortino ratio for AUR, currently valued at 2.39, compared to the broader market-4.00-2.000.002.004.006.002.39
Omega ratio
The chart of Omega ratio for AUR, currently valued at 1.29, compared to the broader market0.501.001.502.001.29
Calmar ratio
The chart of Calmar ratio for AUR, currently valued at 1.71, compared to the broader market0.002.004.006.001.71
Martin ratio
The chart of Martin ratio for AUR, currently valued at 4.85, compared to the broader market0.0010.0020.0030.004.85

CLOV vs. AUR - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 2.42, which is higher than the AUR Sharpe Ratio of 1.69. The chart below compares the historical Sharpe Ratios of CLOV and AUR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
2.42
1.69
CLOV
AUR

Dividends

CLOV vs. AUR - Dividend Comparison

Neither CLOV nor AUR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CLOV vs. AUR - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum AUR drawdown of -93.34%. Use the drawdown chart below to compare losses from any high point for CLOV and AUR. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%JuneJulyAugustSeptemberOctoberNovember
-86.09%
-68.56%
CLOV
AUR

Volatility

CLOV vs. AUR - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 20.62%, while Aurora Innovation, Inc. (AUR) has a volatility of 32.99%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than AUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%JuneJulyAugustSeptemberOctoberNovember
20.62%
32.99%
CLOV
AUR

Financials

CLOV vs. AUR - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Aurora Innovation, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items